Trial no.:
|
PACTR201701001962265 |
Date of Approval:
|
05/01/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Integrated Neuromuscular Inhibition Technique Versus Kinesiotap On Upper Trapezius Myofascial trigger points: Randomised Clinical Trial |
Official scientific title |
integrated neuromuscular inhibition technique versus kinesiotape on pain intensity, pressure pain threshold, range of motion,functional disability and electrical activity of muscle ( muscle amplitude and fatigue) in patient with myofascial trigger points |
Brief summary describing the background
and objectives of the trial
|
Myofascial pain syndrome is one of the common musculoskeletal pain disorders which affects almost 95% of people with chronic pain disorders and is a common finding in specially pain management Centre.It is characterized by trigger points, which are defined as hyperirritable spots within taut bands of skeletal muscle fibers. The syndrome is associated with tenderness in the muscle, referred pain, spasm and restriction of motion.Myofascial pain syndrome responds well when treatment is targeted at the trigger points.integrated neuromuscular inhibition(INIT)is a combination of three treatment technique: ischemic compression, positional release and muscle energy technique.this technique is effective in treatment of trigger points (Nagrale et al., 2010). kinesiotape( KT) is a novel treatment method and its effect on trigger points must be taken seriously. the purpose of the study: to compare between INIT and KT at patients with active trigger points. pilot study will be conducted to detect sample size. the patients of both gender will participate in the study with age ranging from 19 to 38 years old.the patients will be assigned randomly into two equal group A and B.we will assess pain intensity by VAS, pressure pain threshold by algometer, ROM by CROM, functional disability by NDI and electrical activity by EMG. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
INIT KT ROM NDI WMG |
Disease(s) or condition(s) being studied |
myofascial trigger points |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/02/2017 |
Actual trial start date |
|
Anticipated date of last follow up |
01/12/2017 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|